Company profile: Infinity Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of drug discovery and development focused on medicines for the treatment of cancer and related conditions.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Infinity Pharmaceuticals
Kairos Pharma
HQ: United States
Website
- Description: Provider of clinical-stage cancer immunotherapies addressing drug resistance: ENV-105 (Endoglin-targeting antibody; Phase I/II for prostate and lung), KROS-201 (activated T cell therapy for glioblastoma), KROS-101 (GITR agonist), KROS-102 (GITR antagonist), KROS-301 (RelA/NF-κB inhibitor), and KROS-401 (IL4/IL13 cyclic peptide for triple-negative breast cancer, with radiation).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kairos Pharma company profile →
Endomag
HQ: United Kingdom
Website
- Description: Provider of magnetic sensing technologies for breast cancer care, including the Sentimag surgical guidance system to detect tumors and lymph nodes, Magseed markers for precise tissue and lymph node localization, Magtrace lymphatic tracer for sentinel node biopsy with clear signal and visual guidance, and Magseed Pro self-expanding seed for precise deployment and anchoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endomag company profile →
Amcure
HQ: Germany
Website
- Description: Provider of peptide-based compounds in clinical development for the treatment of highly metastatic forms of squamous cancer; a privately held spin-off from the Karlsruhe Institute of Technology established in 2012 and supported by a grant from the German Federal Ministry of Education and Research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amcure company profile →
Applied Proteomics
HQ: United States
Website
- Description: Provider of protein biomarker discovery solutions, including SimpliPro Colon Test—a blood test for healthcare providers to aid colorectal health assessment by measuring 11 protein markers associated with colorectal cancer and advanced adenoma—plus a mass-spectrometry (tandem LCMS) proteomics platform, proprietary workflow management system, and advanced visualization tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Proteomics company profile →
Acrivon Therapeutics
HQ: United States
Website
- Description: Provider of precision oncology therapeutics and companion diagnostics, leveraging the AP3 platform to develop drugs and OncoSignature tests that match therapies to tumor-driving mechanisms. Pipeline includes ACR-368, a phase 2 DNA damage response kinase inhibitor for solid cancers, and ACR-2316, a preclinical selective dual WEE1/PKMYT1 inhibitor.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acrivon Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Infinity Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Infinity Pharmaceuticals
2.2 - Growth funds investing in similar companies to Infinity Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Infinity Pharmaceuticals
4.2 - Public trading comparable groups for Infinity Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →